FDA recall record

Pharmedica USA Purely Soothing 15% MSM Drops recall — FDA D-0456-2023

Non-Sterility

Class Iclassification
D-0456-2023official record ID
Mar 15, 2023report date

Recall record at a glance

Official recordD-0456-2023
CategoryDrug Recalls
ClassificationClass I
FDA record statusOngoing
Recalling firmPharmedica USA, LLC
Report dateMar 15, 2023
Recall initiation dateFeb 14, 2023
Quantitya) 869 bottles; b) 1035 bottles
LocationPhoenix, AZ, United States

Official product description

Purely Soothing 15% MSM Drops, packaged in a)15 ml, .5 fl oz bottle, UPC 7 31034 91382 9; and b) 30 ml, 1.014 fl oz bottle, UPC 7 31034 91379 9; Manufactured by: Pharmedica USA, Phoenix, AZ.

Why the product was recalled

Non-Sterility

Distribution information

Nationwide in the USA and Worldwide through e-commerce and trade shows

How to read the classification

FDA Class I indicates a situation in which there is a reasonable probability that use of or exposure to the product will cause serious adverse health consequences or death. The classification shown here comes directly from the FDA enforcement record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: E-Mail.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.